SH3GL1 and diffuse large B-cell lymphoma: The analysis of Kaplan–Meier revealed that DLBCL patients with high SH3GL1 expression had poor OS (61.79% vs. 93.83%, p = .001) and PFS (42.86% vs. 77.68%, p = .002; Figure 2C,D).